Send to

Choose Destination
Cureus. 2018 Mar 9;10(3):e2291. doi: 10.7759/cureus.2291.

Potential Clinical Benefits of D-ribose in Ischemic Cardiovascular Disease.

Author information

Research and Development, Jacqmar, Inc.


Cardiovascular disease still remains the leading cause of deaths worldwide. Atherosclerosis, the most common type of cardiovascular disease, has continued to progress due to many factors, genetics, and lifestyles. All cells require adequate adenosine triphosphate (ATP) levels to maintain their integrity and function. Myocardial ischemia commonly found in atherosclerosis can produce lower levels of ATP, which affects not only cellular energy, but also alters normal function. D-ribose, a naturally occurring pentose carbohydrate, has been shown to increase cellular energy levels and improve function following ischemia in pre-clinical studies and have demonstrated potential benefits in clinical evaluations. This review paper presents an overview of ischemic cardiovascular disease and the potential role that D-ribose could play in improving myocardial energy levels and function in the area of ischemic cardiovascular diseases.


adenine nucleotides; adenosine triphosphate; cardiology; cardiovascular disease; cardiovascular surgery; clinical benefits; d-ribose; pre-clinical and clinical trials

Conflict of interest statement

There have been 6 issued patents related to this technology

Publication type

Publication type

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center